{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:26:37Z","timestamp":1760865997574},"reference-count":52,"publisher":"Scientific Scholar","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Nephrol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0971-4065.172228","type":"journal-article","created":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T07:40:58Z","timestamp":1467358858000},"page":"244","source":"Crossref","is-referenced-by-count":3,"title":["Pegylated interferon monotherapy for hepatitis C virus infection in patients on hemodialysis: A single center study"],"prefix":"10.25259","volume":"26","author":[{"given":"SK","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Bhowmik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Bagchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0971-4065.172228-1","first-page":"c133","volume-title":"Hepatitis C virus infection in haemodialysis: The 'no-isolation' policy should not be generalized","author":"Agarwal","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"key-10.4103\/0971-4065.172228-2","first-page":"1139","volume-title":"Hepatitis C virus infection during haemodialysis in India","author":"Agarwal","year":"1999","journal-title":"J Assoc Physicians India"},{"key":"key-10.4103\/0971-4065.172228-3","first-page":"981","volume-title":"Hepatitis C virus infection in dialysis and renal transplantation","author":"Pereira","year":"1997","journal-title":"Kidney Int"},{"key":"key-10.4103\/0971-4065.172228-4","first-page":"3040","volume-title":"Hepatitis C in a hemodialysis unit: Molecular evidence for nosocomial transmission","author":"Le","year":"1998","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0971-4065.172228-5","first-page":"532","volume-title":"Results of renal transplantation on conventional immunosuppression in second decade in India: A single centre experience","author":"Agarwal","year":"2002","journal-title":"J Assoc Physicians India"},{"key":"key-10.4103\/0971-4065.172228-6","first-page":"1155","volume-title":"Impact of hepatitis C virus infection on renal transplant outcome in India \u2013 A single centre study","author":"Agarwal","year":"2000","journal-title":"J Assoc Physicians India"},{"key":"key-10.4103\/0971-4065.172228-7","first-page":"479","volume-title":"HCV infection during renal replacement therapy: Should we dialyze all HCV-positive patients on dedicated machines?","author":"Agarwal","year":"1998","journal-title":"Nephron"},{"key":"key-10.4103\/0971-4065.172228-8","first-page":"1061","volume-title":"Assessment of awareness regarding universal precaution among the nursing staff of AIIMS in 1997","author":"Agarwal","year":"1998","journal-title":"J Assoc Physicians India"},{"key":"key-10.4103\/0971-4065.172228-9","doi-asserted-by":"crossref","unstructured":"Guideline 4: Management of HCV-infected patients before and after kidney transplantation. Kidney Int 2008;73 Suppl 109: S53-68.","DOI":"10.1038\/ki.2008.87"},{"key":"key-10.4103\/0971-4065.172228-10","first-page":"120","volume-title":"Virological and histological responses to one year alpha-interferon-2a in hemodialyzed patients with chronic hepatitis C","author":"Hanrotel","year":"2001","journal-title":"Nephron"},{"key":"key-10.4103\/0971-4065.172228-11","first-page":"1507","volume-title":"Interferon treatment for chronic hepatitis C virus infection in uremic patients","author":"Koenig","year":"1994","journal-title":"Kidney Int"},{"key":"key-10.4103\/0971-4065.172228-12","first-page":"1412","volume-title":"Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients","author":"Pol","year":"1995","journal-title":"Kidney Int"},{"key":"key-10.4103\/0971-4065.172228-13","first-page":"55","volume-title":"Interferon-alpha in chronic hepatitis C infection in dialysis patients","author":"Huraib","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0971-4065.172228-14","first-page":"220","volume-title":"Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response","author":"Espinosa","year":"2001","journal-title":"Clin Nephrol"},{"key":"key-10.4103\/0971-4065.172228-15","first-page":"2092","volume-title":"Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation","author":"Kamar","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/0971-4065.172228-16","first-page":"131","volume-title":"The impact of hepatitis C virus viremia on renal graft and patient survival: A 9-year prospective study","author":"Mahmoud","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0971-4065.172228-17","first-page":"1017","volume-title":"The tolerance and efficacy of interferon-alpha in haemodialysis patients with HCV infection: A multicentre, prospective study","author":"Degos","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.172228-18","first-page":"4191","volume-title":"Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis","author":"Sporea","year":"2006","journal-title":"World J Gastroenterol"},{"key":"key-10.4103\/0971-4065.172228-19","first-page":"575","volume-title":"Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C","author":"Kokoglu","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"key-10.4103\/0971-4065.172228-20","first-page":"316","volume-title":"Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients","author":"Bruchfeld","year":"2006","journal-title":"J Viral Hepat"},{"key":"key-10.4103\/0971-4065.172228-21","first-page":"768","volume-title":"The treatment of chronic hepatitis C with peginterferon alfa-2a (40 kDa) plus ribavirin in haemodialysed patients awaiting renal transplant","author":"Rendina","year":"2007","journal-title":"J Hepatol"},{"key":"key-10.4103\/0971-4065.172228-22","first-page":"204","volume-title":"Monotherapy with pegylated interferon alpha-2a in hemodialyzed patients with chronic hepatitis C","author":"Zoppoli","year":"2008","journal-title":"Dial Transplant"},{"key":"key-10.4103\/0971-4065.172228-23","first-page":"99","volume-title":"Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy","author":"Vikrant","year":"2005","journal-title":"Transpl Infect Dis"},{"key":"key-10.4103\/0971-4065.172228-24","first-page":"152","volume-title":"Liver biopsy in patients on hemodialysis with hepatitis C virus infection: An important tool","author":"Agarwal","year":"2015","journal-title":"Indian J Nephrol","ISSN":"http:\/\/id.crossref.org\/issn\/0971-4065","issn-type":"print"},{"key":"key-10.4103\/0971-4065.172228-25","first-page":"599","volume-title":"Lupus activation with cerebritis following pegylated interferon in a hemodialysis patient","author":"Agarwal","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"key-10.4103\/0971-4065.172228-26","first-page":"123","volume-title":"Pegylated interferon-alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C","author":"Annicchiarico","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/0971-4065.172228-27","first-page":"1424","volume-title":"Treatment of hepatitis C virus with interferon in hemodialysis patients awaiting kidney transplant","author":"Rivera","year":"2005","journal-title":"Transplant Proc"},{"key":"key-10.4103\/0971-4065.172228-28","first-page":"991","volume-title":"Pegylated interferon for the treatment of hepatitis C virus in haemodialysis patients","author":"Teta","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.172228-29","first-page":"794","volume-title":"Analysis of safety and efficacy of pegylated-interferon alpha-2a in hepatitis C virus positive hemodialysis patients: Results from a large, multicenter audit","author":"Covic","year":"2006","journal-title":"J Nephrol"},{"key":"key-10.4103\/0971-4065.172228-30","first-page":"437","volume-title":"Randomized trial of pegylated interferon alpha-2b monotherapy in haemodialysis patients with chronic hepatitis C","author":"Russo","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.172228-31","first-page":"2125","volume-title":"Preliminary results of treatment with pegylated interferon alpha 2A for chronic hepatitis C virus in kidney transplant candidates on hemodialysis","author":"Casanovas-Taltavull","year":"2007","journal-title":"Transplant Proc"},{"key":"key-10.4103\/0971-4065.172228-32","first-page":"961","volume-title":"Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy","author":"Sikole","year":"2007","journal-title":"Ren Fail"},{"key":"key-10.4103\/0971-4065.172228-33","first-page":"11","volume-title":"Pilot study of pegylated interferon-alpha 2a in dialysis patients with chronic hepatitis C virus infection","author":"Chan","year":"2007","journal-title":"Nephrology (Carlton)"},{"key":"key-10.4103\/0971-4065.172228-34","first-page":"366","volume-title":"Anemia associated with pegylated interferon-alpha2a and alpha2b therapy in hemodialysis patients","author":"Espinosa","year":"2007","journal-title":"Clin Nephrol"},{"key":"key-10.4103\/0971-4065.172228-35","first-page":"16","volume-title":"Monotherapy with peginterferon alpha-2b {12 kDa} for chronic hepatitis C infection in patients undergoing haemodialysis","author":"Amarapurkar","year":"2007","journal-title":"Trop Gastroenterol"},{"key":"key-10.4103\/0971-4065.172228-36","first-page":"525","volume-title":"Pegylated interferon alpha-2a versus standard interferon alpha-2a for treatment-naive dialysis patients with chronic hepatitis C: A randomised study","author":"Liu","year":"2008","journal-title":"Gut"},{"key":"key-10.4103\/0971-4065.172228-37","first-page":"255","volume-title":"Efficacy and safety of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C","author":"Ayaz","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key-10.4103\/0971-4065.172228-38","first-page":"341","volume-title":"The response to pegylated interferon alpha 2a in haemodialysis patients with hepatitis C virus infection","author":"Akhan","year":"2008","journal-title":"Infection"},{"key":"key-10.4103\/0971-4065.172228-39","first-page":"353","volume-title":"Treatment of hepatitis C in hemodialysis patients using pegylated interferon alpha-2a in Turkey","author":"Kose","year":"2009","journal-title":"J Gastroenterol"},{"key":"key-10.4103\/0971-4065.172228-40","first-page":"410","volume-title":"Safety and efficacy of an escalating dose regimen of pegylated interferon alpha-2b in the treatment of haemodialysis patients with chronic hepatitis C","author":"Tan","year":"2010","journal-title":"J Viral Hepat"},{"key":"key-10.4103\/0971-4065.172228-41","first-page":"53","volume-title":"Pegylated interferon for treatment of chronic hepatitis C in hemodialysis patients in Croatia","author":"Basic-Jukic","year":"2011","journal-title":"Kidney Blood Press Res"},{"key":"key-10.4103\/0971-4065.172228-42","first-page":"242","volume-title":"Low-dose peginterferon alfa-2a is safe and produces a sustained virologic response in patients with chronic hepatitis C and end-stage renal disease","author":"Peck-Radosavljevic","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key-10.4103\/0971-4065.172228-43","first-page":"582","volume-title":"Treatment of hepatitis C virus infection in patients on maintenance hemodialysis: A single United Arab Emirates center experience","author":"Giguere","year":"2011","journal-title":"Eur J Intern Med"},{"key":"key-10.4103\/0971-4065.172228-44","first-page":"189","volume-title":"Treatment of chronic hepatitis C in end stage renal disease: Experience at a tertiary care centre","author":"Duseja","year":"2012","journal-title":"Trop Gastroenterol"},{"key":"key-10.4103\/0971-4065.172228-45","first-page":"729","volume-title":"Pegylated interferon-a2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial","author":"Liu","year":"2013","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0971-4065.172228-46","first-page":"789","volume-title":"Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: A comparison of 2 sequentially treated cohorts","author":"Tseng","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0971-4065.172228-47","first-page":"115","volume-title":"Virological responses of pegylated interferon alpha-2a treatment in hemodialysis patients infected with hepatitis C","author":"K\u00f6se","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"key-10.4103\/0971-4065.172228-48","first-page":"603","volume-title":"Multicenter study of pegylated interferon \u03b1-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH study","author":"Kikuchi","year":"2014","journal-title":"Ther Apher Dial"},{"key":"key-10.4103\/0971-4065.172228-49","first-page":"4071","volume-title":"Efficacy and tolerability of low-dose interferon-\u03b1 in hemodialysis patients with chronic hepatitis C virus infection","author":"Wang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key-10.4103\/0971-4065.172228-50","first-page":"1061","volume-title":"Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C","author":"McHutchison","year":"2002","journal-title":"Gastroenterology"},{"key":"key-10.4103\/0971-4065.172228-51","first-page":"34","volume-title":"Do differences in pegylation of interferon alfa matter?","author":"Zeuzem","year":"2010","journal-title":"Gastroenterology"},{"key":"key-10.4103\/0971-4065.172228-52","first-page":"140953","volume-title":"Evolution of interferon-based therapy for chronic hepatitis C","author":"Chen","year":"2010","journal-title":"Hepat Res Treat"}],"container-title":["Indian Journal of Nephrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T19:40:12Z","timestamp":1712173212000},"score":1,"resource":{"primary":{"URL":"https:\/\/indianjnephrol.org\/pegylated-interferon-monotherapy-for-hepatitis-c-virus-infection-in-patients-on-hemodialysis-a-single-center-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"alternative-id":["172228"],"URL":"https:\/\/doi.org\/10.4103\/0971-4065.172228","relation":{},"ISSN":["0971-4065"],"issn-type":[{"value":"0971-4065","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}